Clinical Trial Software · Clinical Trial Sites & Recruitment
Advarra news and milestones
Advarra: 35 headlines on record, 14 headlines in the last 90 days. Its story counts 2 milestones.
Data updated Nov 17, 2026 · Back to the company report
35Headlines
14In 90 days
2Milestones
Headlines
Oct 82026
News · clin trials
While there has been a number of recent initiatives put into place to support diversity, equity, and inclusion in clinical trials, there is still a considerable amount of room fo…
Oct 82026
News · clin trials
How today's SSO reduces site burden and spearheads clinical system interoperability.
Oct 82026
News · clin trials
In this video interview, Jeff Sidell, PhD, chief technology officer, Advarra, talks AI and how it can automate repetitive processes.
Oct 62026
Blog
Clinical trial audits are independent quality assurance evaluations of trial activities, records, systems, facilities, and organizations. The main types include: Investigator sit…
Oct 52026
Blog
Christy Frey has spent nearly two decades helping research move forward-ethically, efficiently, and always with people in mind. As senior director of IRB services at Advarra, she…
Oct 12026
Sep 292026
Blog
Investigator-initiated trials (IITs) play a critical role in advancing clinical research by allowing investigators to pursue important scientific questions beyond traditional spo…
Sep 282026
Blog
The U.S. Office of Information and Regulatory Affairs (OIRA), within the Office of Management and Budget (OMB), released the federal government's 2026 Regulatory Plan and the Uni…
Sep 282026
Blog
Planned changes outlined in the U.S. federal government's 2026 Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions (Unified Agenda) could reshap…
Sep 282026
Blog
On July 3, 2026, the U.S. Office of Information and Regulatory Affairs (OIRA), within the Office of Management and Budget (OMB), released the government's 2026 Regulatory Plan an…
Sep 282026
Blog
With all the buzz recently on regulatory reform for institutional review boards (IRBs), it's worth looking back to the foundation of today's human research protections. The guidi…
Sep 242026
Blog
In fall 2026, the Advarra-facilitated Site-Sponsor Consortium will release a white paper on reducing redundant site training through competency-based, role-based, and reusable tr…
Sep 112026
Blog
Researchers often want to know early whether a study will be considered Not Human Subjects Research (NHSR), exempt, eligible for expedited review, or likely to require full board…
Sep 102026
Blog
When it comes to unnecessary protocol complexity, the cracks often show up later. Amendments. Delayed activation. Added site burden. By the time these consequences become visible…
Nov 13, 20252025
News · Yahoo News
The development of the integration has commenced and initial collaboration with customers is underway.
Aug 6, 20252025
Press release · PRNewswire
/PRNewswire/ -- Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced a major expansion of...
Feb 19, 20252025
News · BioSpace
Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving patient trust and the overall viability of clinical t…
Jan 22, 20252025
News · YahooFinance
The solution integrates Longboat
Jan 8, 20252025
News · DIA Global Forum
A number of expert sources shared with Global Forum their additional predictions on new topics for 2025. They are grouped by contributor or contributing organization.
Jan 8, 20252025
News · DIA Global Forum
In an era where artificial intelligence (AI) is revolutionizing healthcare and clinical research, regulatory bodies are racing to keep pace.
Jan 8, 20252025
News · BioSpace
Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, oncology and reaping the benefits of AI.
Dec 21, 20232023
Mar 9, 20212021
News · newswise.com
Advarra, the market leader in regulatory review solutions, research quality and compliance consulting services and clinical site-centric technologies, today announced that it has…
Jan 7, 20212021
Press release · streetinsider.com
Apr 20, 20202020
Press release · PRNewswire
/PRNewswire/ -- Advarra, the premier provider of institutional review board (IRB), institutional biosafety committee (IBC), research technology solutions, and...
News · The Medicine Maker
Ophthalmology is quietly becoming gene therapy's next big frontier. Here's how the science, the patients, and the regulations are aligning.
News · EdClinical
AI in clinical trials is moving fast - but without clear standards for ethics, transparency, or oversight. Advarras new Council for Responsible Use of AI in Clinical Trials aims…
News · contractpharma.com
Advarras Christine Senn discusses compelling data from a recent site feasibility survey, the opportunity for…
News · clinicaltrialvanguard.com
Advarra has launched the Council for Responsible AI in Clinical Trials to ensure the ethical…
News · contractpharma.com
See this staff-written news brief highlighting AMRs selection of Longboat.
News · biospectrumasia.com
This staff-written feature article discusses the predictions for 2025 from industry leaders, including Advarras Jeff…
News · primr.org
New programming will equip research oversight professionals with independent education, leadership dialogue, and practical resources…
News · calameo.com
Check out this informative read about the importance of Data Monitoring Committees in multi-site oncology…
News · nxtbook.com
Beyond the Breakthrough explores the challenges of CAR-T oncology trials, from complex logistics and safety…
News · EdClinical
The impact of the "one-and-done PI" has long been discussed in clinical trials. But what does the research show, and should we even be concerned about this phenomenon?
Sources: the outlets named on each headline, each story once
Milestones
Apr 20, 2020
Each milestone is dated by its source: registers, filings, the press
How to cite
Advarra, News. Alion, Nov 17, 2026. https://alion.io/company/advarra/news
